Evolving applications of microarray technology in postnatal diagnosis (Review)

Kang,Ji  Un; Koo,Sun  Hoe

doi:10.3892/ijmm.2012.988

Evolving applications of microarray technology in postnatal diagnosis (Review)

Authors:
- Ji Un Kang
- Sun Hoe Koo
View Affiliations

Affiliations: Department of Biomedical Laboratory Science, Korea Nazarene University, Cheonan, Republic of Korea, Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Published online on: May 9, 2012 https://doi.org/10.3892/ijmm.2012.988
Pages: 223-228

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Microarray-based cytogenetics is revealing the tremendous fluidity and complexity of the human genome, and is starting to illustrate the implications of genomic variability with respect to human health and disease. In the last few years, the robustness of array-based technologies has provided accurate diagnosis and appropriate clinical management in a timely and efficient manner for identifying genomic defects of congenital and developmental abnormalities including developmental delay (DD), intellectual disability (ID), autism spectrum disorders (ASD) and/or multiple congenital anomalies (MCA). The implementation of this technology in these categories of disorders has been thoroughly evaluated and is now recommended as a first-line diagnostic approach for clinically suspected genetic disorders. However, clinical application of array-CGH in postnatal evaluation raises the debate of whether array-CGH will replace traditional cytogenetics in the near future and whether there is still a role for karyotyping and FISH. In this article, we therefore review the current status of array-based technology use for postnatal diagnosis and predict that it will replace standard cytogenetics as a first-line test for clinical evaluation in these population groups.

View Figures

View References

1.	MR SpeicherNP CarterThe new cytogenetics: blurring the boundaries with molecular biologyNat Rev Genet6782792200510.1038/nrg169216145555
2.	JP MaciejewskiGJ MuftiWhole genome scanning as a cytogenetic tool in hematologic malignanciesBlood112965974200810.1182/blood-2008-02-13043518505780
3.	JU KangSH KooKC KwonJW ParkJM KimIdentification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of the lungBMC Cancer9237200919607727
4.	GS SagooAS ButterworthS SandersonC Shaw-SmithJP HigginsH BurtonArray CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjectsGenet Med11139146200910.1097/GIM.0b013e318194ee8f19367186
5.	R HochstenbachE van BinsbergenJ EngelenArray analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the NetherlandsEur J Med Genet52161169200910.1016/j.ejmg.2009.03.015
6.	Y ShenKA DiesIA HolmClinical genetic testing for patients with autism spectrum disordersPediatrics125727735201010.1542/peds.2009-168420231187
7.	L EdelmannK HirschhornClinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomaliesAnn NY Acad Sci1151157166200910.1111/j.1749-6632.2008.03610.x19154522
8.	SG VorsanovaYB YurovIY IourovHuman interphase chromosomes: a review of available molecular cytogenetic technologiesMol Cytogenet31201010.1186/1755-8166-3-120180947
9.	BA BejjaniLG ShafferApplication of array-based comparative genomic hybridization to clinical diagnosticsJ Mol Diagn8528533200610.2353/jmoldx.2006.06002917065418
10.	BA BejjaniLG ShafferClinical utility of contemporary molecular cytogeneticsAnnu Rev Genomics Hum Genet97186200810.1146/annurev.genom.9.081307.16420718949852
11.	LG ShafferBA BejjaniMedical applications of array CGH and the transformation of clinical cytogeneticsCytogenet Genome Res115303309200610.1159/00009592817124414
12.	H TönniesModern molecular cytogenetic techniques in genetic diagnosticsTrends Mol Med82462502002
13.	KD LichtenbeltNV KnoersGH Schuring-BlomFrom karyotyping to array-CGH in prenatal diagnosisCytogenet Genome Res135241250201110.1159/00033406522086062
14.	BA BejjaniR SalekiBC BallifEA RoremK SundinA TheisenCD KashorkLG ShafferUse of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more?Am J Med Genet A134259267200510.1002/ajmg.a.3062115723295
15.	JR VermeeschH FieglerN de LeeuwGuidelines for molecular karyotyping in constitutional genetic diagnosisEur J Hum Genet1511051114200710.1038/sj.ejhg.520189617637806
16.	BJ DaveWG SangerRole of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalancesSemin Pediatr Neurol1426200710.1016/j.spen.2006.11.00317331878
17.	American College of Obstetricians and GynecologistsACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosisObstet Gynecol11411611163200910.1097/AOG.0b013e3181c33cad20168129
18.	BB de VriesR PfundtM LeisinkDiagnostic genome profiling in mental retardationAm J Hum Genet77606616200516175506
19.	P StankiewiczAL BeaudetUse of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardationCurr Opin Genet Dev17182192200710.1016/j.gde.2007.04.00917467974
20.	LE VissersBB de VriesK OsoegawaArray-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalitiesAm J Hum Genet7312611270200310.1086/37997714628292
21.	C Shaw-SmithR RedonL RickmanMicroarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic featuresJ Med Genet412412424128200410.1136/jmg.2003.017731
22.	JR VermeeschC MelotteG FroyenMolecular karyotyping: array CGH quality criteria for constitutional genetic diagnosisJ Histochem Cytochem53413422200510.1369/jhc.4A6436.200515750031
23.	DT MillerMP AdamS AradhyaConsensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomaliesAm J Hum Genet86749764201010.1016/j.ajhg.2010.04.00620466091
24.	TH BuiA VetroO ZuffardiLG ShafferCurrent controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era?Prenat Diagn31235243201110.1002/pd.272221374637
25.	BH FaasI van der BurgtAJ KooperIdentification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysisJ Med Genet47586594201010.1136/jmg.2009.075853
26.	SC HillmanS PretloveA CoomarasamyDJ McMullanEV DavisonER MaherMD KilbyAdditional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysisUltrasound Obstet Gynecol37614201110.1002/uog.7754